Mechanisms of postprandial hyperglycemia in liver transplant recipients: Comparison of liver transplant patients with kidney transplant patients and healthy controls

Diabetes and Metabolism

Volumn 26, Issue 1, 2000, Pages 51-56

  Schneiter, Ph ^c   Gillet, M ^a   Chiolero R ^a   Jequier E ^c   Mosimann, F ^a   Temler, E ^a   Teta D ^a   Matter, M ^a   Wauters, J P ^a   Tappy, L ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c NONE

Author keywords

C peptide; Glucose metabolism; Insulinemia; Kidney transplantation; Liver transplantation

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POSTPRANDIAL STATE;

ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; REFERENCE VALUES; TIME FACTORS;

EID: 0034016448     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Runyon BA. Treatment of patients with cirrhosis and ascites. Seminars in Liver Disease, 1997, 17, 249-260.
2. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Safely, 1997, 16, 242-257.
3. Jindal RM. Posttransplant diabetes mellitus - a review. Transplantation, 1994, 58, 1289-1298.
4. Rizza R, Mandarine L, Gerich J. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab, 1982, 54, 131-138.
5. Dresner LS, Andersen DK, Kahng KU, Munshi IA, Wait RB. Effects of cyclosporin on glucose metabolism. Surgery, 1989, 106, 163-170.
6. Tabasco-Minguillan J, Mieles L, Carroll P, et al. Insulin requirements after liver transplantation and FK-506 immunosuppression. Transplantation, 1993, 56, 862-867.
7. Gerich JE. Control of glycaemia. Baillieres Clin Endocrinol Metab. 1993, 7, 551-586.
8. Shimazu T. Central nervous system regulation of liver and adipose tissue metabolism. Diabetologia, 1981, 20, 343-356.
9. Myers SR, Biggers DW, Neal DW, Cherrington AD. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest, 1991, 88, 158-167.
10. Galassetti P, Shiota M, Zinker BA, Wasserman DH, Cherrington AD. A negative arterial-portal vein glucose gradient decreases skeletal muscle glucose uptake in the conscious dog. Am J Physiol. 1998, 275, E101-E111.
11. Hevener A, Bergman R, Donovan C. Novel glucosensor for hypoglycemic detention localized to the portal vein. Diabetes, 1997, 46, 1521-1525.
12. Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ. How to measure insulin clearance. Diabetes Metab Rev, 1994, 10, 119-150.
13. Schneiter P, Gillet M, Chioléro R, Berger M, Tappy L. Postprandial hepatic glycogen synthesis in liver transplant recipients. Transplantation, 1998, in press.
14. Schneiter P, Gillet M, Chioléro R, Jéquier E, Tappy L. Non oxidative disposal of an oral glucose meal in patients with liver cirrhosis. Metabolism, in press.
15. Durnin JVGA, Womersley J. Body fat assessment for total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr, 1974, 32, 77-97.
16. DeBodo R, Steele R, Altszuler N, Dunn A, Bishop J. On the hormonal regulation of carbohydrate metabolism: studies with 14C-glucose. Recent Prog Horm Res, 1963, 19, 445-488.
17. Tappy L, Dussoix P, Iynedjian P, et al. Abnormal regulation of hepatic glucose output in Maturity Onset Diabetes of the Young caused by a specific mutation of the glucokinase gene. Diabetes, 1997, 46, 204-208.
18. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1998, 21 (Suppl. 1), S5-S19.
19. Dinneen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest, 1993, 92, 2283-2290.
20. Dinneen SF: The effects of glucocorticoid hormones on substrate metabolism, in: Draznin B. Rizza R (ed.): Clinical Research in Diabetes and Obesity, Totowa, N.J., Humana Press, 1997, 243-258 vol I.
21. Schneiter P, Tappy L. Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. Am J Physiol, 1998, 275, E806-E813.
22. Perseghin G, Regalia E, Battezzati A, et al. Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest, 1997, 100, 931-941.
23. Petrides AS, DeFronzo RA. Glucose metabolism in cirrhosis: A review with some perspectives for the future. Diabetes Metab Rev, 1989, 5, 691-709.
24. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med, 1992, 326, 22-29.
25. Perseghin G, Price TB, Petersen KF, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med, 1996, 335, 1357-1362.
26. Lamarche L, Yamaguchi N, Peronnet F. Hepatic dencrvation reduces adrenal catecholamine secretion during insulin-induced hypoglycemia. Am J Physiol, 1995, 270, R1307-R1316.
27. Moore MC, Cherrington AD. The nerves, the liver, and the route of feeding: an integrated response to nutrient delivery. Nutrition, 1996, 12, 282-284.